GLP-1 Receptor Agonist
Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Originally developed for type 2 diabetes management, it has shown significant efficacy in weight management clinical trials. Our research-grade semaglutide is synthesized to ≥99% purity.
- Molecular Weight: 4,113.58 g/mol
- Sequence: Modified GLP-1 (7-37) analog
- Purity: ≥99% (HPLC verified)
- Storage: -20°C, lyophilized
Total
$249.00
+ $25.00 Flat Rate Shipping
For research use only. By purchasing, you agree to our terms of service.
Common Schedule
Semaglutide Titration Timeline
Gradually increasing your dose helps minimize side effects and allows your body to adjust. Consult your healthcare provider for personalized guidance.
Weeks 1–4
0.25 mg
Starting dose
Weeks 5–8
0.5 mg
Per week dose
Weeks 9–12
1.0 mg
Per week dose
Weeks 13–16
1.7 mg
Per week dose
Week 17+
2.4 mg
Maintenance
Weeks 1–4Starting dose
0.25 mg
Weeks 5–8Per week dose
0.5 mg
Weeks 9–12Per week dose
1.0 mg
Weeks 13–16Per week dose
1.7 mg
Week 17+Maintenance
2.4 mg